AUPM885894A0 - Therapeutic molecules - Google Patents
Therapeutic moleculesInfo
- Publication number
- AUPM885894A0 AUPM885894A0 AUPM8858A AUPM885894A AUPM885894A0 AU PM885894 A0 AUPM885894 A0 AU PM885894A0 AU PM8858 A AUPM8858 A AU PM8858A AU PM885894 A AUPM885894 A AU PM885894A AU PM885894 A0 AUPM885894 A0 AU PM885894A0
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic molecules
- therapeutic
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM8858A AUPM885894A0 (en) | 1994-10-18 | 1994-10-18 | Therapeutic molecules |
AU36457/95A AU3645795A (en) | 1994-10-18 | 1995-10-17 | Therapeutic molecules |
PCT/AU1995/000683 WO1996011942A1 (en) | 1994-10-18 | 1995-10-17 | Therapeutic molecules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM8858A AUPM885894A0 (en) | 1994-10-18 | 1994-10-18 | Therapeutic molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPM885894A0 true AUPM885894A0 (en) | 1994-11-10 |
Family
ID=3783376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPM8858A Abandoned AUPM885894A0 (en) | 1994-10-18 | 1994-10-18 | Therapeutic molecules |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPM885894A0 (en) |
WO (1) | WO1996011942A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ551700A0 (en) * | 2000-02-09 | 2000-03-02 | Unisearch Limited | Blood clotting related enzyme |
US7179784B2 (en) * | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
DE10163130B4 (en) | 2001-12-20 | 2009-05-14 | Cyto Tools Gmbh | Apoptotic peptides and pharmaceutical compositions comprising them |
JP2010539032A (en) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | Use of BUBUC and optional EAA-MART1 (26-35) as a therapeutic agent for HCMV infection |
US20220160812A1 (en) * | 2019-05-22 | 2022-05-26 | Cytopharma Gmbh | A pharmaceutically active substance |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399667A (en) * | 1993-03-05 | 1995-03-21 | Washington University | Thrombospondin receptor binding peptides |
-
1994
- 1994-10-18 AU AUPM8858A patent/AUPM885894A0/en not_active Abandoned
-
1995
- 1995-10-17 WO PCT/AU1995/000683 patent/WO1996011942A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996011942A1 (en) | 1996-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3401895A (en) | Spiro-azabicyclic compounds useful in therapy | |
EP1015578A4 (en) | Therapeutic molecules | |
AUPO203996A0 (en) | Therapeutic uses | |
AU2805195A (en) | Therapeutic compounds | |
AU9403798A (en) | Human regulatory molecules | |
AU5478496A (en) | Therapeutic amides | |
AU2263197A (en) | Diabetes therapy | |
AU4145096A (en) | Resuscitator | |
AU4267396A (en) | Modified cannula | |
AU1184399A (en) | Therapeutic molecules | |
AU5119296A (en) | Magnetotherapy unit | |
AU4344996A (en) | Vessel-puncturing cannula | |
AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
AU3391895A (en) | Supports | |
AU2512495A (en) | Therapeutic phenoxyalkylazoles and phenoxyalkylazines | |
AUPM885894A0 (en) | Therapeutic molecules | |
AU2154695A (en) | Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof | |
AUPP263498A0 (en) | Novel therapeutic molecules and uses therefor | |
AU1289695A (en) | Human stanniocalcin-alpha | |
AU3645795A (en) | Therapeutic molecules | |
AU1714195A (en) | Therapeutic benzonitriles | |
AU4104997A (en) | Therapeutic molecules | |
AUPO226296A0 (en) | Therapeutic molecules | |
AU3885995A (en) | Novel medicinal use | |
AUPO926397A0 (en) | Novel therapeutic molecules |